Author Policies

Manuscript Preparation

Authors submitting to Cancer Studies and Molecular Medicine – Open Journal must follow the prescribed manuscript preparation guidelines to ensure clarity, consistency, and proper presentation of their research. Manuscripts should include the following sections: title, abstract, keywords, introduction, methods, results, discussion, conclusion, and references. The abstract should summarize the main findings of the study in a concise and clear manner, typically under 250 words. Figures and tables must be high quality, clearly labeled, and placed at appropriate sections within the text. Authors are required to submit the manuscript in Word or PDF format, following the journal’s specific citation style (e.g., Vancouver, APA). Manuscripts should be written in clear, concise English, avoiding unnecessary jargon. For studies involving human or animal subjects, authors must include proof of ethical approval from relevant ethics committees and include statements of informed consent where applicable. The manuscript should also adhere to the appropriate ethical standards for research integrity. Authors are encouraged to use the journal's sample paper as a template for formatting their submission.

Complaints Policy

Cancer Studies and Molecular Medicine – Open Journal is dedicated to maintaining transparency and fairness in its editorial and peer review processes. If authors, reviewers, or readers have any complaints or concerns regarding the editorial process, ethical issues, or the handling of manuscripts, they are encouraged to contact the editorial office. All complaints will be treated with confidentiality and reviewed by the editorial team. If necessary, a formal investigation will be conducted to address the issue, and the complainant will be notified of the findings. In cases where complaints relate to ethical misconduct (e.g., plagiarism or data fabrication), the journal will take immediate action, including investigation, possible retraction, or correction of published articles. The journal encourages constructive feedback and is committed to ensuring a fair and impartial process. If authors feel that their concerns have not been addressed satisfactorily, they may appeal the editorial decision. The editorial board will handle all complaints in a transparent and professional manner, ensuring the integrity of the journal’s publishing process is upheld.

Participant/Patient Privacy and Informed Consent

The journal upholds strict ethical guidelines to protect the privacy and rights of participants in research involving human subjects. Authors must confirm that informed consent has been obtained from all human participants involved in their studies. This consent must include details about the study’s nature, its purpose, and any potential risks or benefits of participation. Additionally, authors must ensure that any personal or identifiable information is anonymized or de-identified to protect participant privacy. Research involving human subjects must have prior approval from an Institutional Review Board (IRB) or an equivalent ethics committee. For studies involving vulnerable populations, special care must be taken to ensure that consent is obtained in an ethically sound manner. The journal also encourages authors to adhere to local and international ethical standards such as the Declaration of Helsinki and the General Data Protection Regulation (GDPR) in Europe. Ethical compliance ensures the safety and privacy of research participants and contributes to the credibility of the published research.

Human and Animal Rights Policy

Cancer Studies and Molecular Medicine – Open Journal is committed to ensuring that all research involving human and animal subjects is conducted in adherence to ethical standards and regulations. Research involving human participants must comply with the Declaration of Helsinki, ensuring that studies are designed with respect for human rights and dignity. Authors must provide proof of ethical approval from an institutional review board (IRB) or ethics committee before submitting their manuscript. Similarly, studies involving animals must comply with the principles of the 3Rs (Replacement, Reduction, and Refinement) and should be approved by an animal ethics committee. Authors must adhere to relevant national and international guidelines, such as those set by the National Institutes of Health (NIH) or the Animal Welfare Act. Ethical considerations in research are paramount to maintaining public trust in scientific findings and ensuring that both human and animal subjects are treated with respect and care throughout the research process.

APC Waiver Policy

Cancer Studies and Molecular Medicine – Open Journal recognizes that financial barriers may prevent some authors from publishing in open-access journals. To promote inclusivity, the journal offers waivers or discounts on the Article Processing Charge (APC) for authors from low-income or middle-income countries, as well as for authors who can demonstrate financial hardship. Waiver requests must be submitted during the submission process and should include relevant documentation to support the claim. These may include proof of the author’s institution's financial status or evidence of the author's personal financial circumstances. Each waiver request will be reviewed on a case-by-case basis by the editorial team. The journal is committed to ensuring that all qualified researchers, regardless of their financial situation, can share their work openly with the scientific community.

Author’s Agreement Form

Prior to the publication of their article, authors must sign the Author’s Agreement Form. This form grants Cancer Studies and Molecular Medicine – Open Journal the exclusive right to publish the article under a Creative Commons Attribution (CC BY) license. The agreement also confirms that the manuscript is the author’s original work and that it has not been previously published elsewhere. The form requires authors to disclose any potential conflicts of interest and to ensure compliance with ethical guidelines, including obtaining ethical approval for studies involving human or animal subjects. The Author’s Agreement ensures that both the author’s and the journal’s rights are clearly defined and protects the intellectual property of the author while allowing the article to be shared and reused under the terms of open-access publishing.

English Language Editing

To assist authors whose first language is not English, Cancer Studies and Molecular Medicine – Open Journal offers English language editing services. These services help authors enhance the clarity, grammar, and structure of their manuscripts to ensure that they meet the journal’s high standards for publication. While the journal provides editing assistance to improve the readability of the manuscript, the authors are ultimately responsible for the accuracy and content of their work. Authors are encouraged to thoroughly review the edited manuscript to ensure that the scientific meaning remains unchanged. The journal’s goal is to support authors in presenting their research in the best possible way while maintaining the integrity of the original content.

Digital Preservation

To ensure the long-term availability and accessibility of published research, Cancer Studies and Molecular Medicine – Open Journal partners with reputable digital preservation services such as Portico and LOCKSS (Lots of Copies Keep Stuff Safe). These services provide secure, long-term storage of articles, ensuring that content remains accessible even if the journal website experiences downtime or closure. The journal also uses proper metadata to enhance discoverability and indexing, ensuring that articles are easily accessible to researchers worldwide. The digital preservation policy reflects the journal’s commitment to ensuring that published research remains freely available and discoverable long after publication.

Article Processing Charge (APC)

Authors of accepted articles are required to pay an Article Processing Charge (APC) to cover the costs of publishing, including peer review, editorial services, and the dissemination of the article. The APC is payable upon acceptance of the manuscript and is necessary to support the journal’s open-access publishing model, allowing articles to be freely available to all readers. The APC helps offset the costs associated with maintaining the journal’s high standards of publishing, including professional editing, peer review management, and indexing. For authors in low-income or middle-income countries, APC discounts or waivers are available upon request. Details of the APC will be provided at the time of submission.

Copyright Policy

Upon acceptance of their manuscript, authors grant Cancer Studies and Molecular Medicine – Open Journal the right to publish the article under a Creative Commons Attribution (CC BY) license. This means that authors retain the copyright to their work but allow others to freely share, adapt, and build upon it, as long as proper attribution is given to the original authors. The policy ensures the dissemination of research while protecting the intellectual property of authors. Authors are free to use their published work for other purposes, such as in books, presentations, or other publications, as long as the terms of the Creative Commons license are followed.

Errata, Retractions, and Corrigenda Policy

In the event that a published article contains errors, Cancer Studies and Molecular Medicine – Open Journal will issue an erratum or corrigendum to correct the mistakes. If the article is found to contain significant errors or ethical violations, such as data fabrication or plagiarism, the journal may retract the article. Retractions will be clearly indicated, and a statement explaining the retraction will be published. The journal strives for transparency and accuracy in its published work and is committed to maintaining the integrity of its content by promptly addressing any issues related to errors or misconduct.

Open Access Policy

Cancer Studies and Molecular Medicine – Open Journal follows an open-access publishing model, ensuring that all published articles are freely available to anyone, anywhere in the world, without subscription or paywalls. This open-access model promotes the dissemination of scientific knowledge and supports the global exchange of information. Authors retain copyright over their work and publish under a Creative Commons Attribution (CC BY) license, which allows others to freely share, reuse, and build upon the research, provided proper attribution is given to the original authors. The journal is committed to fostering global collaboration and the open sharing of research findings.

Rights and Grants to the Author

Authors retain full copyright over their work but grant Cancer Studies and Molecular Medicine – Open Journal the right to publish their article under a Creative Commons Attribution (CC BY) license. This license permits others to reuse, share, and adapt the work as long as proper attribution is given to the original author. The journal does not claim ownership of the work but ensures that the research is widely disseminated and freely accessible. Authors can republish their work in other venues as long as they adhere to the terms of the Creative Commons license. The policy ensures that the author’s intellectual property is protected while promoting the broadest possible dissemination of research.

Withdrawal Policy

Authors

may request the withdrawal of their manuscript from Cancer Studies and Molecular Medicine – Open Journal at any stage of the submission process before it is formally accepted. The withdrawal request must be submitted in writing, with the corresponding author providing a valid reason for the withdrawal. Once a manuscript is accepted for publication or has entered the production process, withdrawal is generally not permitted unless there are exceptional circumstances such as ethical concerns or significant errors discovered after acceptance. If a manuscript is withdrawn after acceptance, it will be clearly noted in the journal’s records.

Licensing Policy

All articles published in Cancer Studies and Molecular Medicine – Open Journal are licensed under a Creative Commons Attribution (CC BY) license, unless otherwise stated. This license allows others to freely copy, distribute, and adapt the article, provided proper attribution is given to the original authors. This open-access licensing policy ensures that research is widely disseminated and shared within the global scientific community. The licensing policy promotes the free exchange of scientific knowledge while respecting the intellectual property rights of the authors.

Sample Paper

Cancer Studies and Molecular Medicine – Open Journal provides a sample paper on its website to guide authors in preparing their manuscripts. This sample includes the journal’s required formatting, structure, and citation style. Authors are encouraged to use the sample paper as a reference to ensure that their submission adheres to the journal's formatting requirements. The sample paper covers all sections of the manuscript, from the title page to the references, providing a clear template for authors to follow.

Plagiarism Policy

Cancer Studies and Molecular Medicine – Open Journal has a strict zero-tolerance policy regarding plagiarism. All submitted manuscripts are screened for plagiarism using reliable plagiarism detection tools. Authors must ensure that all work submitted is original and that any sources, data, or ideas derived from other works are properly cited. In cases where plagiarism is identified, the manuscript will be rejected, and the author may be banned from submitting future work. If plagiarism is discovered after publication, the article will be retracted, and a public retraction notice will be issued. The journal is committed to upholding the highest standards of research integrity.

Data Sharing Policy

Cancer Studies and Molecular Medicine – Open Journal encourages authors to make their research data publicly available to support transparency and reproducibility. Authors should submit data to publicly accessible repositories or provide supplementary data with their manuscript. Sharing data enhances the credibility of research findings and supports the scientific community's ability to replicate and build upon previous studies. Authors should ensure that their data complies with ethical standards, particularly regarding human or animal subject data, and that all necessary permissions for sharing have been obtained.

Check List

Before submitting a manuscript to Cancer Studies and Molecular Medicine – Open Journal, authors must review a submission checklist to ensure that their manuscript meets all the journal’s requirements. The checklist includes ensuring that the manuscript is formatted according to the journal’s guidelines, that all sections are complete, and that all necessary documents (e.g., conflict-of-interest statement, ethical approval) are included. This checklist helps streamline the submission process and ensures that the manuscript will be processed without unnecessary delays.

Submission of Manuscript

To submit a manuscript to Cancer Studies and Molecular Medicine – Open Journal, authors must use the online submission system, where they can upload their manuscript, supporting documents, and any additional materials. The submission must comply with the journal’s formatting and content requirements. Upon submission, authors will receive a confirmation email, and their manuscript will be assigned to a handling editor for the initial review. All authors must ensure that the manuscript is original, has not been submitted to other journals, and adheres to the ethical standards set by the journal.